{"Introduction": [131, 868, 0, 2819, 6077, 0], "Methods and analysis": [869, 1670, 0, 6078, 21115, 1], "Ethics and dissemination": [1671, 2115, 0, 21116, 22801, 1], "Trial registration number": [2116, 2169, 0], "Strengths and limitations of this study": [2170, 2818, 0], "Study design, randomisation, intervention and study calendar": [6100, 7610, 0], "Inclusion criteria": [8532, 9324, 0], "Exclusion criteria": [9325, 10481, 0], "Study implementation, recruitment, population and eligibility criteria": [7611, 10481, 1], "Safety measures and monitoring": [10482, 13082, 0], "Primary outcome": [13927, 14190, 0], "Secondary outcomes": [14191, 14493, 0], "Biological markers": [14494, 14812, 0], "Outcome measures": [13083, 14812, 1], "Data collection and management": [14813, 17778, 0], "Sample size": [17807, 18601, 0], "Interim analysis": [18602, 19289, 0], "Statistical analysis": [19290, 21009, 0], "Statistical considerations": [17779, 21009, 1], "Patient and public involvement": [21010, 21115, 0], "Ethics and safety approval": [21142, 21680, 0], "Informed consent": [21681, 22294, 0], "Dissemination": [22295, 22801, 0], "Trial status": [25777, 25836, 0], "Discussion": [22802, 25836, 1], "Supplementary Material": [25837, 25864, 0]}